H1N1 seasonal influenza virus vaccine (Vaxart)

N/A

Report date: 2022/07/19 20:00:45

Base Information

Drug NameH1N1 seasonal influenza virus vaccine (Vaxart)
Drug Alias NameSeasonal influenza vaccine (Vaxart)Ad-HA-dsRNA (Vaxart)VXA-A1.1
ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulantsToll like receptor 3 agonists
TargetsToll like receptor 3
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesVaxart Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVaxart Inc
Active IndicationsN/A
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A